Menu Search
Equities

Top Glove Corporation Bhd

BVA:SES

Top Glove Corporation Bhd

Actions
Health CareMedical Equipment and Services
  • Price (SGD)0.33
  • Today's Change0.005 / 1.54%
  • Shares traded284.40k
  • 1 Year change+53.49%
  • Beta-0.6400
Data delayed at least 10 minutes, as of Nov 15 2024 06:42 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in MYRIncome statement in MYRView more

Year on year Top Glove Corporation Bhd grew revenues 11.46% from 2.26bn to 2.52bn while net income improved from a loss of 878.61m to a smaller loss of 15.20m.
Gross margin--
Net profit margin-0.72%
Operating margin-1.44%
Return on assets-0.26%
Return on equity-1.06%
Return on investment-0.30%
More ▼

Cash flow in MYRView more

In 2024, Top Glove Corporation Bhd increased its cash reserves by 23.13%, or 66.02m. Cash Flow from Investing totalled 248.39m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 37.76m in cash from operations while cash used for financing totalled 184.62m.
Cash flow per share0.0336
Price/Cash flow per share33.52
Book value per share0.7227
Tangible book value per share0.6152
More ▼

Balance sheet in MYRView more

Top Glove Corporation Bhd has a Debt to Total Capital ratio of 6.76%, a higher figure than the previous year's 0.67%.
Current ratio1.95
Quick ratio1.57
Total debt/total equity0.0729
Total debt/total capital0.0676
More ▼

Growth rates in MYR

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		93.30
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.